Overview
What is Quantum Leap Healthcare Collaborative?
Quantum Leap Healthcare Collaborative is a nonprofit organization based in San Francisco, California, with a mission to support healthcare research organizations, specifically those focused on breast cancer. They provide management and financial assistance to further their initiatives. One of their notable projects is the I-SPY Trials. This program aims to revolutionize clinical trials by identifying the right drug for the right patient at the optimal time, reducing costs, and shortening the overall trial duration. The I-SPY Trials integrate various phases to create a pipeline of novel breast cancer agents and accelerate the process of bringing these drugs to market. The organization has a workforce of 113 employees.
Official website here: www.quantumleaphealth.org
Is Quantum Leap Healthcare Collaborative legitimate?
Quantum Leap Healthcare Collaborative is a legitimate nonprofit organization registered as a 501(c)(3) entity. Quantum Leap Healthcare Collaborative submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $1,090,719
Professional Fundraising Fees: $0
Other Salaries and Wages: $12,102,560
For more financial information, click here
Official website here: www.quantumleaphealth.org
What is the mission statement of Quantum Leap Healthcare Collaborative?
The Quantum Leap Healthcare Collaborative is dedicated to supporting healthcare research organizations, with a focus on breast cancer research and treatment. They sponsor innovative clinical trials, such as the I-SPY Trials, which aim to match the right drug to the right patient at the most beneficial time, reducing overall costs, time, and patients required to bring new drugs to market. The I-SPY Trials program integrates phase I, II, and future phases, building a pipeline of novel agents and accelerating the identification of high-risk breast cancer patients who will benefit from these new agents. Ultimately, the Collaborative's mission is to advance healthcare research and treatments, particularly for breast cancer, to improve patient outcomes.
Official website here: www.quantumleaphealth.org
Who is the CEO of Quantum Leap Healthcare Collaborative?
James Palazzolo is the Chairman of Quantum Leap Healthcare Collaborative. The CEO's salary of Quantum Leap Healthcare Collaborative is $508,333 and their total compensation is $548,746.
Official website here: www.quantumleaphealth.org
What is the revenue of Quantum Leap Healthcare Collaborative?
Quantum Leap Healthcare Collaborative's revenue in 2022 was $47,253,845.
Official website here: www.quantumleaphealth.org
Who are the executives of Quantum Leap Healthcare Collaborative and what are their salaries?
The average compensation at Quantum Leap Healthcare Collaborative during 2022 was $116,755. There are 113 employees and 12 volunteers at Quantum Leap Healthcare Collaborative.
Here are 21 key members and their salaries (Quantum Leap Healthcare Collaborative's CEO's salary is $508,333 and their total compensation is $548,746):
- James Palazzolo (Ceo)
- Kathryn Watson-Feiner (Vice President Of Finance And Administration)
- Karyn Digiorgio (Chief Collaboration Officer)
- Paul Henderson (Sr. Director Of Collaborations)
- Tracey Heather (Director Of Development)
- Maria Pitsiouni (Director, Clinical Operations Oncology)
- Sara Horton (Executive Director, Access & Diversity)
- Adam Asare (Chief Data Officer)
- Dave Mandelkern (Chairman) [Trustee/Director]
- Laura Esserman (Director, Cofounder)
- Jeffrey Pfeffer (Director, Cofounder)
- Susan Foley (Treasurer) [Trustee/Director]
- Anna Barker (Director)
- Lucas De Breed (Director)
- Michele Markus (Director)
- Robert Patterson (Director)
- Robyn Lawrie Rutledge (Director)
- Gregory C Simon (Director)
- Mark Simon (Director)
- N Marcus Thygeson (Director)
- Lambert Van Der Walde (Director)
Official website here: www.quantumleaphealth.org
Where can I find the form 990 for Quantum Leap Healthcare Collaborative?
The Quantum Leap Healthcare Collaborative’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.quantumleaphealth.org
Learn more at the official website: www.quantumleaphealth.org
Mission Statement of Quantum Leap Healthcare Collaborative
Quantum Leap Healthcare Collaborative, a healthcare research organization supporter, is dedicated to providing management and financial assistance, with a significant focus on breast cancer research and treatment. The nonprofit organization plays a vital role in the healthcare sector by sponsoring groundbreaking initiatives like the I-SPY Trials.
The I-SPY Trials, an innovative program by Quantum Leap Healthcare Collaborative, redefines clinical trials with the goal to match the right drug with the right patient at the most beneficial time. This approach aims to reduce overall costs, time, and the number of patients required to bring new drugs to market. The I-SPY Trials consist of three distinct phases, I-SPY 1, I-SPY 2, and future phases, all linked together to create a pipeline of novel agents and expedite the identification of high-risk breast cancer patients who will benefit from these new agents. The program strives to get these drugs into the clinic efficiently.
Impact
This information is meant to be a general summary of Quantum Leap Healthcare Collaborative. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Quantum Leap Healthcare Collaborative's impact lies in revolutionizing the approach to clinical trials through its sponsorship of the I-SPY Trials. These trials aim to streamline the process of getting the right drug to the right patient at the most beneficial time, significantly reducing the overall cost, time, and number of patients required to bring new drugs to market. By integrating and linking different phases of trials, Quantum Leap is accelerating the identification of high-risk breast cancer patients who will benefit from novel treatments, ultimately bringing these drugs to the clinic in a timely manner.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
CLINICAL TRIAL CONTRAC
Revenue
$26,914,608
CONSULTING AND RESEARC
Revenue
$951,120
Organization Details
Founding Year
2005
Phone
(855) 866-0505
Principal Officer
James Palazzolo
Main Address
499 ILLINOIS AVE 200, SAN FRANCISCO, CA, 94158
Website
www.quantumleaphealth.org
NTEE Category
Code: J40 - Employment
If you are a representative of Quantum Leap Healthcare Collaborative and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.